First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

VIFN price has not been updated for more than 1 month. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of VIFN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIFN Relative Value
Base Case
Not Available
V
Worst Case
Base Case
Best Case

Valuation Multiples

6.1
P/S
P/S
Price to Sales
6.1
vs History
vs Industry
Median 3Y
6.2
Median 5Y
6
Industry
2.4
Forward
5.7
More Details
74.7
P/E
P/E
Price to Earnings
74.7
vs History
vs Industry
Median 3Y
74.7
Median 5Y
73.8
Industry
22.9
Forward
44.9
More Details
20.4
P/OCF
P/OCF
Price to OCF
20.4
vs History
vs Industry
Median 3Y
20.5
Median 5Y
20.5
Industry
17.1
More Details
38
P/FCFE
P/FCFE
Price to FCFE
38
vs History
vs Industry
Median 3Y
38
Median 5Y
38
Industry
23.2
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
vs Industry
Median 3Y
3.1
Median 5Y
3.1
Industry
2.1
More Details
5.6
EV/S
EV/S
Enterprise Value to Sales
5.6
vs History
vs Industry
Median 3Y
5.7
Median 5Y
5.7
Industry
2.6
Forward
5.2
More Details
9.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.2
vs History
vs Industry
Median 3Y
9.2
Median 5Y
9.2
Industry
5.1
More Details
14.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.7
vs History
vs Industry
Median 3Y
14.8
Median 5Y
15.2
Industry
13.6
Forward
15.6
More Details
28.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
28.2
vs History
vs Industry
Median 3Y
28.2
Median 5Y
28.9
Industry
17
Forward
24.3
More Details
18.8
EV/OCF
EV/OCF
Enterprise Value to OCF
18.8
vs History
vs Industry
Median 3Y
18.8
Median 5Y
18.8
Industry
15.8
More Details
32.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32.1
vs History
vs Industry
Median 3Y
32.1
Median 5Y
32.1
Industry
17.6
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.5
Industry
1.9
More Details

Multiples Across Competitors

VIFN Competitors Multiples
Vifor Pharma AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Vifor Pharma AG
SIX:VIFN
10.8B CHF 6.1 74.7 14.7 28.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
728.1B USD 21.3 138.7 62.7 72
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.9 46.8 34.2 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
704.3B JPY 2.2 83.6 9.5 23.2
US
Johnson & Johnson
NYSE:JNJ
361.3B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
326.6B USD 5.3 141.6 33.7 53.4
UK
AstraZeneca PLC
LSE:AZN
188.2B GBP 5.1 39.5 140.7 225.7
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
171.2B CHF 2.9 14.9 8.5 10.1

See Also

Summary
VIFN intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIFN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIFN stock valuation using valuation multiples.
Wall Street Estimates
VIFN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIFN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.